Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 9, 2007, Pages 1625-1636

  Li, Yi ^a   Yang, Xiaojing ^a   Nguyen, Alana H T ^a   Brockhausen, Inka ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Apoptosis; Fas; Glycoprotein; Glycosylation; Glycosyltransferases; HeLa cells

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIBODY; FAS ANTIGEN; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; HYBRID PROTEIN; RECOMBINANT PROTEIN; TUNICAMYCIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIGENS, CD95; APOPTOSIS; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HELA CELLS; HUMANS; LECTINS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS;

EID: 34547098850     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.04.002     Document Type: Article

References (48)

1. Axelsson M.A., Karlsson N.G., Steel D.M., Ouwendijk J., Nilsson T., and Hansson G.C. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins. Glycobiology 11 (2001) 633-644
2. Bajorath J. Analysis of Fas-ligand interactions using a molecular model of the receptor-ligand interface. Computer Aided Molecular Design 13 (1999) 409-418
3. Berger E.G., Grimm K., Bachi T., Bosshart H., Kleene R., and Muller U. Double immunofluorescent staining of alpha-2,6-sialyltransferase and beta-1,4-galactosyltransferase in monensin-treated cells: Evidence for different Golgi compartments?. Journal of Cellular Biochemistry 52 (1993) 275-288
4. Berger E.G., Thurnher M., and Muller U. Galactosyltransferase and sialyltransferase are located in different subcellular compartments in HeLa cells. Experimental Cell Research 173 (1987) 267-273
5. Borsig L., Kleene R., Dinter A., and Berger E.G. Immunodetection of alpha 1-3 fucosyltransferase (FucT-V). European Journal of Cell Biology 70 (1996) 42-53
6. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochimica et Biophysica Acta 1473 (1999) 67-95
7. Brockhausen I. The role of galactosyltransferases in cell surface functions and in the immune system. Drug News and Perspectives 19 (2006) 401-409
8. Brockhausen I., Lehotay M., Yang J.M., Qin W., Young D., Lucien J., et al. Glycoprotein biosynthesis in porcine aortic endothelial cells and changes in the apoptotic cell population. Glycobiology 12 (2002) 33-45
9. Brockhausen I., Schutzbach J.S., and Kuhns W. Glycoproteins and their relationship to human disease. Acta Anatomica 161 (1998) 36-78
10. Brockhausen I., Yang J., Lehotay M., Ogata S., and Itzkowitz S. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression. Biological Chemistry 382 (2001) 219-232
11. Brockhausen I., Yang X., and Harrison M. Analysis of the glycodynamics of primary osteoblasts and bone cancer cells. Glycobiology protocols in methods in molecular biology (2006), Humana Press, NJ pp. 211-236
12. Carlsson S.R., Roth J., Piller F., and Fukuda M. Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. Journal of Biological Chemistry 263 (1988) 18911-18919
13. Chang J.Y., and Korolev V.V. Specific toxicity of tunicamycin in induction of programmed cell death of sympathetic neurons. Experimental Neurology 137 (1996) 201-211
14. Dalziel M., Whitehouse C., McFarlane I., Brockhausen I., Gschmeissner S., Schwientek T., et al. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. Journal of Biological Chemistry 276 (2001) 11007-11015
15. Davis-Fleische K.M., Brigstock D.R., and Besner G.E. Site-directed mutagenesis of heparin-binding EGF-like growth factor (HB-EGF): Analysis of O-glycosylation sites and properties. Growth Factors 19 (2001) 127-143
16. Debatin K.M., Fahrig-Faissner A., Enenkel-Stoodt S., Kreuz W., Benner A., and Krammer P.H. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83 (1994) 3101-3103
17. Fadeel B., Lindberg J., Achour A., and Chiodi F. A three-dimensional model of the Fas/APO-1 molecule: Cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. International Immunology 10 (1998) 131-140
18. Fadeel B., Thorpe J., and Chiodi F. Mapping the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb. International Immunology 7 (1995) 1967-1975
19. Gabius H.J. Probing the cons and pros of lectin-induced immunomodulation: Case studies for the mistletoe lectin and galectin-1. Biochimie 83 (2001) 659-666
20. Grodzicky T., and Elkon K.B. Apoptosis in rheumatic diseases. American Journal of Medicine 108 (2000) 73-82
21. Hanabuchi S., Koyanagi M., Kawasaki A., Shinohara N., Matsuzawa A., Nishimura Y., et al. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 4930-4934
22. Hiraishi K., Suzuki K., Hakomori S., and Adachi M. Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology 3 (1993) 381-390
23. Keppler O.T., Peter M.E., Hinderlich S., Moldenhauer G., Stehling P., Schmitz I., et al. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 9 (1999) 557-569
24. Kojima N., Handa K., Newman W., and Hakomori S. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochemical and Biophysical Research Communications 182 (1992) 1288-1295
25. Martinez J.A., Torres-Negrom I., Amigo L.A., Roldan R.A., Mendez A., and Banerjee D.K. Tunicamycin inhibits capillary endothelial cell proliferation by inducing apoptosis. Targeting dolichol-pathway for generation of new anti-angiogenic therapeutics. Advances in Experimental Medicine and Biology 476 (2000) 197-208
26. Muraki M. Secretory expression of synthetic human Fas ligand extracellular domain gene in Pichia pastoris: Influences of tag addition and N-glycosylation site deletion, and development of a purification method. Protein Expression and Purification 50 (2006) 137-146
27. Nagata S., and Goldstein P. The Fas death factor. Science 267 (1995) 1449-1456
28. Nagata S., and Suda T. Fas and Fas ligand: lpr and gld mutations. Immunology Today 16 (1995) 39-43
29. Nguyen T.T., and Amara S.G. N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. Journal of Neurochemistry 67 (1996) 645-655
30. Nilsson T., Hoe M.H., Slusarewicz P., Rabouille C., Watson R., Hunte F., et al. Kin recognition between medial Golgi enzymes in HeLa cells. EMBO Journal 13 (1994) 562-574
31. Nilsson T., Pypaert M., Hoe M.H., Slusarewicz P., Berger E., and Warren G. Overlapping distribution of two glycosyltransferases in the Golgi apparatus of HeLa cells. Journal of Cell Biology 120 (1993) 5-13
32. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., et al. Purification and molecular cloning of the Apo-1 Cell surface antigen, a member of the tumor necrosis factor-nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. Journal of Biological Chemistry 267 (1992) 10709-10715
33. Orlinick J.R., Elkon K.B., and Chao M.V. Separate domains of the human fas ligand dictate self-association and receptor binding. Journal of Biological Chemistry 272 (1997) 32221-32229
34. Perez-Sala D., and Mollinedo F. Inhibition of N-linked glycosylation induces early apoptosis in human promyelocytic HL-60 cells. Journal of Cellular Physiology 163 (1995) 523-531
35. Perillo N.L., Marcus M.E., and Baum L.G. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. Journal of Molecular Medicine 76 (1998) 402-412
36. Prescott A.R., Lucocq J.M., James J., Lister J.M., and Ponnambalam S. Distinct compartmentalization of TGN46 and beta 1,4-galactosyltransferase in HeLa cells. European Journal of Cell Biology 72 (1997) 238-246
37. Rabinovich G.A., and Gruppi A. Galectins as immunoregulators during infectious processes: From microbial invasion to the resolution of the disease. Parasite Immunology 27 (2005) 103-114
38. Rapoport E., and Le Pendu J. Glycosylation alterations of cells in late phase apoptosis from colon carcinomas. Glycobiology 9 (1999) 1337-1345
39. Röttger S., White J., Wandall H.H., Olivo J.C., Stark A., Bennett E.P., et al. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. Journal of Cell Science 111 (1998) 45-60
40. Schneider P., Bodmer J.L., Holler N., Mattmann C., Scuderi P., Terskikh A., et al. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. Journal of Biological Chemistry 272 (1997) 18827-18833
41. Schneider P., and Tschopp J. Apoptosis induced by death receptors. Pharmaceutica Acta Helvetiae 74 (2000) 281-286
42. Starling G.C., Bajorath J., Emswiler J., Ledbetter J.A., Aruffo A., and Kiener P.A. Identification of amino acid residues important for ligand binding to Fas. Journal of Experimental Medicine 185 (1997) 1487-1492
43. Starling G.C., Kiener P.A., Aruffo A., and Bajorath J. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40. Biochemistry 37 (1998) 3723-3726
44. Tian E., Hagen K.G., Shum L., Hang H.C., Imbert Y., Young Jr. W.W., et al. An inhibitor of O-glycosylation induces apoptosis in NIH3T3 cells and developing mouse embryonic mandibular tissues. Journal of Biological Chemistry 279 (2004) 50382-50390
45. Yang X., Lehotay M., Anastassiades T., Harrison M., and Brockhausen I. The effect of TNFalpha On glycosylation pathways in bovine synoviocytes. Biochemistry Cell Biology 82 (2004) 559-568
46. Yang X., Yip J., Anastassiades T., Harrison M., and Brockhausen I. The action of TNFalpha and TGFbeta include specific alterations of the glycosylation of bovine and human chondrocytes. Biochimica et Biophysica Acta 1773 (2007) 264-272
47. Yoshimi M., Sekiguchi T., Hara N., and Nishimoto T. Inhibition of N-linked glycosylation causes apoptosis in hamster BHK21 cells. Biochemical and Biophysical Research Communication 276 (2000) 965-969
48. Yotsuyanagi H., Shintani Y., Moriya K., Fujie H., Tsutsumi T., Kimura S., et al. Regulation of Fas gene expression in HeLa cells as determined by modified RT-PCR. Cellular and Molecular Life Sciences 54 (1998) 186-190